Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Operating expenses:        
Research and development $ 1,069,716 $ 745,000 $ 3,261,747 $ 1,034,700
General and administrative 1,535,617 708,084 3,893,100 873,888
Total operating expenses 2,605,333 1,453,084 7,154,847 1,908,588
Loss from operations (2,605,333) (1,453,084) (7,154,847) (1,908,588)
Other expense, net 6,495 3,259 21,876 3,202
Net loss $ (2,611,828) $ (1,456,343) $ (7,176,723) $ (1,911,790)
Net loss per share - basic and diluted (in dollars per share) $ (0.08) $ (0.10) $ (0.22) $ (0.13)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 32,060,796 14,895,604 32,020,265 14,895,604